CBD caused developmental delays in worm models but at doses far above human recommendations
In C. elegans, CBD exposure from the onset of feeding caused irreversible developmental delays, while purified CBD was slightly more toxic than CBD in hemp extract, though all adverse effects occurred at doses far exceeding recommended human intake.
Quick Facts
What This Study Found
CBD delayed developmental milestone acquisition irreversibly when exposure began at the onset of feeding, while locomotor effects were reversible after removing CBD. Purified CBD was slightly more toxic than matched CBD concentrations in hemp extract across all endpoints. Juveniles were more sensitive than adults.
Key Numbers
All adverse effect levels in C. elegans far exceeded recommended CBD dosages for humans. Purified CBD was slightly more toxic than hemp extract at matched concentrations. CBD reduced high-fat-diet-induced oxidative stress in adults.
How They Did This
C. elegans nematodes were exposed to purified CBD or hemp extract in sesame oil emulsions. Researchers measured oxidative stress response, developmental timing, locomotor activity, reproductive output, and organismal CBD concentrations across juvenile and adult life stages.
Why This Research Matters
As CBD products become more widely available, understanding their effects on development and reproduction is important. This study flags that early-life CBD exposure may cause irreversible developmental effects, even if adult effects are reversible.
The Bigger Picture
CBD is increasingly consumed as a supplement, but developmental toxicology data remain limited. While these worm-model findings cannot be directly applied to humans, they highlight that timing of exposure matters and that developing organisms may be more vulnerable than adults.
What This Study Doesn't Tell Us
C. elegans is an extremely simple model organism. Doses causing adverse effects far exceeded human recommended levels. The sesame oil vehicle acts as a high-fat diet in C. elegans, which complicates interpretation. Translation to mammalian development is uncertain.
Questions This Raises
- ?Do similar irreversible developmental effects occur in mammalian models at lower CBD doses?
- ?Why is purified CBD slightly more toxic than hemp extract CBD?
- ?What makes juveniles more sensitive than adults?
Trust & Context
- Key Stat:
- All adverse CBD doses far exceeded recommended human intake
- Evidence Grade:
- Preliminary animal model study using C. elegans. While results flag developmental concerns, the extremely simple organism and high doses limit direct relevance to human CBD use.
- Study Age:
- Published in 2024 in Frontiers in Toxicology.
- Original Title:
- Assessment of the effects of cannabidiol and a CBD-rich hemp extract in Caenorhabditis elegans.
- Published In:
- Frontiers in toxicology, 6, 1469341 (2024)
- Authors:
- Camacho, Jessica A, Welch, Bonnie, Ferguson, Martine, Sepehr, Estatira, Vaught, Cory, Zhao, Yang, Fitzpatrick, Suzanne, Yourick, Jeffrey, Sprando, Robert L, Hunt, Piper Reid
- Database ID:
- RTHC-05172
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Were the CBD doses used in this study relevant to humans?
The researchers noted that all adverse effect levels in C. elegans far exceeded recommended CBD dosages for humans, meaning these findings represent a worst-case scenario rather than typical consumer exposure.
Is purified CBD more dangerous than hemp extract?
In this study, purified CBD was slightly more toxic than equivalent doses of CBD within hemp extract. This could suggest other compounds in hemp extract have a buffering effect, but more research is needed.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-05172APA
Camacho, Jessica A; Welch, Bonnie; Ferguson, Martine; Sepehr, Estatira; Vaught, Cory; Zhao, Yang; Fitzpatrick, Suzanne; Yourick, Jeffrey; Sprando, Robert L; Hunt, Piper Reid. (2024). Assessment of the effects of cannabidiol and a CBD-rich hemp extract in Caenorhabditis elegans.. Frontiers in toxicology, 6, 1469341. https://doi.org/10.3389/ftox.2024.1469341
MLA
Camacho, Jessica A, et al. "Assessment of the effects of cannabidiol and a CBD-rich hemp extract in Caenorhabditis elegans.." Frontiers in toxicology, 2024. https://doi.org/10.3389/ftox.2024.1469341
RethinkTHC
RethinkTHC Research Database. "Assessment of the effects of cannabidiol and a CBD-rich hemp..." RTHC-05172. Retrieved from https://rethinkthc.com/research/camacho-2024-assessment-of-the-effects
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.